OLIGONUCLEOTIDE THERAPY FOR WOLMAN DISEASE AND CHOLESTERYL ESTER STORAGE DISEASE

作者: Cheung-Ong Kahlin , Sun Mark , Merico Daniele

DOI:

关键词:

摘要: The present disclosure provides antisense oligonucleotides, compositions, and methods that target a LIPA intron flanking exon 8, thereby modulating splicing of pre-mRNA to increase the level mRNA molecules having e.g., provide therapy for Wolman Disease or Cholesteryl Ester Storage Disease. an oligonucleotide including nucleobase sequence at least 70% complementary in 5'-flanking intron, 3'-flanking combination 8 intron.

参考文章(3)
Wilhelmus Wenceslaus Matthias Pijnappel, Arnoldus Reuser, Atze Jacobus Bergsma, Erik Van Der Wal, Antje Tjitske Van Der Ploeg, Methods for characterizing alternatively or aberrantly spliced mrna isoforms ,(2015)
Ante Sven Lundberg, Ami Meda Kabadi, Chad Albert Cowan, Materials and methods for treatment of duchenne muscular dystrophy ,(2016)
Sabine Sewing, Marcel Gubler, Régine Gérard, Blandine Avignon, Yasmin Mueller, Annamaria Braendli-Baiocco, Marielle Odin, Annie Moisan, GalNAc Conjugation Attenuates the Cytotoxicity of Antisense Oligonucleotide Drugs in Renal Tubular Cells. Molecular therapy. Nucleic acids. ,vol. 14, pp. 67- 79 ,(2019) , 10.1016/J.OMTN.2018.11.005